Can the Phoenix Sign be Elicited With D5W
Part of paid clinical trials in Marietta, Georgia.
- Sponsor
- US Neuropathy Centers
- Study ID
- NCT07568470
- Status
- Enrolling By Invitation
Conditions
- Drop Foot
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Infiltration of D5W — DRUGThere is no other intervention.
Study Details
To determine if the Phoenix sign can be reliably elicited with non-guided subcutaneous infiltration of D5W (5% Dextrose in Water) in patients with subclinical weakness of the extensor hallucis longus (EHL) muscle.
Key Dates
- Start date
- Apr 10, 2026
- Status verified
- Apr 2026
- Primary completion
- Sep 1, 2026
- Completion
- Jan 15, 2027
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- NA
- Intervention model
- SEQUENTIAL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Infiltration of D5W3 cc's of D5W will be infiltrated subcutaneously at the level of the fibular neck to see if there is any improvement in dorsiflexion strength at 4 and 10 minutes post infiltration.
Primary Outcome Measure
Changes in motor strength of dorsiflexion of the anterior and lateral compartments of the lower extremity [ Time Frame: From enrollment to end of their treatment at 1 day ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| US Neuropathy Centers | Marietta | Georgia | 30067 | - |
Find similar trials in Marietta, GA
By research site